Literature DB >> 18032937

The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up.

Ram Rangsin1, Phunlerd Piyaraj, Thira Sirisanthana, Narongrid Sirisopana, Onsri Short, Kenrad E Nelson.   

Abstract

OBJECTIVE: We evaluated the progression to AIDS and death among 228 men who seroconverted within a 6-month window when in the Royal Thai Army between 1991 and 1995. DESIGN AND METHODS: Men (N = 228) who seroconverted to HIV at 21-23 years of age between 1991 and 1995 were evaluated up to 14 years after HIV seroconversion. The seroconverters were matched with men who were seronegative when they were discharged from the military. In 2005-2006, the vital status was determined through the national mortality database and survivors were contacted for follow-up clinical and immunological assessment. Death certificates, medical records and next of kin interviews were used to evaluate the causes of death.
RESULTS: As of March 2006, among 228 seroconverters, 56 (24.6%) were alive, 171 (75.0%) had died and one (0.4%) had undetermined status. Among 255 HIV-seronegative individuals at baseline, 15 (5.9%) had died. The median time from HIV seroconversion to death was 7.8 years. The median time to AIDS death was 8.4 years. The median times from seroconversion to clinical AIDS and a CD4 cell count less than 200 cells/mul were 7.2 years and 6.5 years, respectively. The median time from seroconversion to World Health Organization criteria for antiretroviral therapy was 6.3 years.
CONCLUSION: Our data indicate a more rapid progression to AIDS and death after HIV-1 infection among young Thai men than has been reported in similar aged men who were HAART-naive in western high income countries.

Entities:  

Mesh:

Year:  2007        PMID: 18032937     DOI: 10.1097/01.aids.0000299409.29528.23

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  19 in total

1.  Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.

Authors:  Habib O Ramadhani; Charles Muiruri; Venance P Maro; Balthazar Nyombi; Michael Omondi; Julian B Mushi; Eileen S Lirhunde; John A Bartlett
Journal:  AIDS Behav       Date:  2018-05

2.  Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Authors:  Jérémie Prévost; Daria Zoubchenok; Jonathan Richard; Maxime Veillette; Beatriz Pacheco; Mathieu Coutu; Nathalie Brassard; Matthew S Parsons; Kiat Ruxrungtham; Torsak Bunupuradah; Sodsai Tovanabutra; Kwan-Ki Hwang; M Anthony Moody; Barton F Haynes; Mattia Bonsignori; Joseph Sodroski; Daniel E Kaufmann; George M Shaw; Agnès L Chenine; Andrés Finzi
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

3.  HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection.

Authors:  Rajesh T Gandhi; Ronald J Bosch; Ram Rangsin; Thippawan Chuenchitra; Narongrid Sirisopana; Jerome H Kim; Merlin L Robb; Sasijit Vejbaesya; Robert M Paris; Kenrad E Nelson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-18       Impact factor: 2.205

4.  Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network.

Authors:  Peter D Ghys; Basia Zaba; Maria Prins
Journal:  AIDS       Date:  2007-11       Impact factor: 4.177

5.  Appreciating HIV type 1 diversity: subtype differences in Env.

Authors:  Rebecca M Lynch; Tongye Shen; S Gnanakaran; Cynthia A Derdeyn
Journal:  AIDS Res Hum Retroviruses       Date:  2009-03       Impact factor: 2.205

6.  Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.

Authors:  Daria Zoubchenok; Maxime Veillette; Jérémie Prévost; Eric Sanders-Buell; Kshitij Wagh; Bette Korber; Agnès L Chenine; Andrés Finzi
Journal:  J Virol       Date:  2017-01-31       Impact factor: 6.549

7.  Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.

Authors:  Oon Tek Ng; Li Lin; Oliver Laeyendecker; Thomas C Quinn; Yong Jiang Sun; Cheng Chuan Lee; Yee Sin Leo
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

8.  Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand.

Authors:  Marcos Pérez-Losada; David V Jobes; Faruk Sinangil; Keith A Crandall; Miguel Arenas; David Posada; Phillip W Berman
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

9.  A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.

Authors:  Supranee Buranapraditkun; Ursula Hempel; Patrawadee Pitakpolrat; Rachel L Allgaier; Pattarawat Thantivorasit; Sven-Iver Lorenzen; Sunee Sirivichayakul; William H Hildebrand; Marcus Altfeld; Christian Brander; Bruce D Walker; Praphan Phanuphak; Pokrath Hansasuta; Sarah L Rowland-Jones; Todd M Allen; Kiat Ruxrungtham
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

10.  Exploring Thailand's mortality transition with the aid of life tables.

Authors:  Gordon A Carmichael
Journal:  Asia Pac Viewp       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.